03/25/2024 5:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:20 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:25 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:33 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:15 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:19 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:32 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/14/2024 3:33 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:47 PM | Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:22 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:22 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:55 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:11 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:51 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:40 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:43 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:45 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:48 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:27 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:33 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 4:17 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 3:18 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/08/2024 6:46 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:25 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:28 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:15 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:24 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:26 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:29 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:00 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:05 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:07 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:11 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:14 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:43 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 4:04 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 4:47 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 10:52 AM | BlackRock Inc. (Filed by) Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024 3:17 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:31 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:15 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 5:26 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:32 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:31 PM | Neurocrine Biosciences (Subject) RASTETTER WILLIAM H (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:31 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:08 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:10 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:15 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:21 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:22 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:22 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:22 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:18 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 6:09 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 5:23 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:32 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:33 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:54 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 7:01 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 4:41 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 3:36 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 3:12 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 6:02 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023 8:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 4:07 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:51 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:09 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 6:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Altcoin FRENZY Alert… (Ad) Bitcoin recently crossed the highest price in its 15-year history…
Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen!
Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days…
Like Fetch.ai, that gained over 350% in just the last 30 days…
Click here now to register for the event (FOR FREE!) |
09/01/2023 3:36 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:31 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:16 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023 3:18 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 3:42 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 3:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 7:20 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:58 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:59 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |